カテゴリ： 世界, 医療/バイオ, QYResearch

出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他

■ 英語タイトル：Global Bleeding Disorder Treatment Drug Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7429）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7429
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は出血性疾患治療薬のグローバル市場について調査・分析し、世界の出血性疾患治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口式、静脈注射式、その他）、用途別セグメント分析（血友病A、血友病B、フォン・ヴィレブランド病、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AbbVie Inc、Alnylam Pharmaceuticals Inc.、Bayer AG、CSL Behring（CSL Limited）、Grifols S.A.、Johnson & Johnson、Novo Nordisk A/S、Octapharma AG、Pfizer Inc.、Sanofi S.A.、Takeda Pharmaceutical Company Limited、Wellona Pharmaなどが含まれています。出血性疾患治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、出血性疾患治療薬市場規模を算出する際に考慮しました。

・出血性疾患治療薬市場の概要
- 出血性疾患治療薬の種類別セグメント
- 世界の出血性疾患治療薬市場規模：タイプ別分析（経口式、静脈注射式、その他）
- 出血性疾患治療薬の用途別セグメント
- 世界の出血性疾患治療薬市場規模：用途別分析（血友病A、血友病B、フォン・ヴィレブランド病、その他）
- 世界の出血性疾患治療薬市場規模予測（2018年-2029年）

・出血性疾患治療薬市場の成長トレンド
- 出血性疾患治療薬の地域別市場規模（2018年-2029年）
- 出血性疾患治療薬市場ダイナミクス
- 出血性疾患治療薬の業界動向
- 出血性疾患治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：経口式、静脈注射式、その他
- 世界の出血性疾患治療薬のタイプ別市場規模（2018年-2023年）
- 世界の出血性疾患治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：血友病A、血友病B、フォン・ヴィレブランド病、その他
- 世界の出血性疾患治療薬の用途別市場規模（2018年-2023年）
- 世界の出血性疾患治療薬の用途別市場規模（2024年-2029年）

・出血性疾患治療薬の地域別市場規模
- 北米の出血性疾患治療薬市場規模（2018年-2029年）
- 米国の出血性疾患治療薬市場規模（2018年-2029年）
- ヨーロッパの出血性疾患治療薬市場規模（2018年-2029年）
- アジア太平洋の出血性疾患治療薬市場規模（2018年-2029年）
- 中国の出血性疾患治療薬市場規模（2018年-2029年）
- 日本の出血性疾患治療薬市場規模（2018年-2029年）
- 韓国の出血性疾患治療薬市場規模（2018年-2029年）
- インドの出血性疾患治療薬市場規模（2018年-2029年）
- オーストラリアの出血性疾患治療薬市場規模（2018年-2029年）
- 中南米の出血性疾患治療薬市場規模（2018年-2029年）
- 中東・アフリカの出血性疾患治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AbbVie Inc、Alnylam Pharmaceuticals Inc.、Bayer AG、CSL Behring（CSL Limited）、Grifols S.A.、Johnson & Johnson、Novo Nordisk A/S、Octapharma AG、Pfizer Inc.、Sanofi S.A.、Takeda Pharmaceutical Company Limited、Wellona Pharma

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Bleeding Disorder Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Bleeding Disorder Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bleeding Disorder Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Bleeding Disorder Treatment Drug in Hemophilia A is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Bleeding Disorder Treatment Drug include AbbVie Inc, Alnylam Pharmaceuticals Inc., Bayer AG, CSL Behring（CSL Limited）, Grifols S.A., Johnson & Johnson, Novo Nordisk A/S, Octapharma AG and Pfizer Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bleeding Disorder Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bleeding Disorder Treatment Drug.
The Bleeding Disorder Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bleeding Disorder Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bleeding Disorder Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbbVie Inc
Alnylam Pharmaceuticals Inc.
Bayer AG
CSL Behring（CSL Limited）
Grifols S.A.
Johnson & Johnson
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Wellona Pharma
Segment by Type
Oral
Intravenous Injection
Others
Segment by Application
Hemophilia A
Hemophilia B
Von Willebrand Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bleeding Disorder Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bleeding Disorder Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Intravenous Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Bleeding Disorder Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Willebrand Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bleeding Disorder Treatment Drug Market Perspective (2018-2029)
2.2 Bleeding Disorder Treatment Drug Growth Trends by Region
2.2.1 Global Bleeding Disorder Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bleeding Disorder Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Bleeding Disorder Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Bleeding Disorder Treatment Drug Market Dynamics
2.3.1 Bleeding Disorder Treatment Drug Industry Trends
2.3.2 Bleeding Disorder Treatment Drug Market Drivers
2.3.3 Bleeding Disorder Treatment Drug Market Challenges
2.3.4 Bleeding Disorder Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bleeding Disorder Treatment Drug Players by Revenue
3.1.1 Global Top Bleeding Disorder Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Bleeding Disorder Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Bleeding Disorder Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bleeding Disorder Treatment Drug Revenue
3.4 Global Bleeding Disorder Treatment Drug Market Concentration Ratio
3.4.1 Global Bleeding Disorder Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bleeding Disorder Treatment Drug Revenue in 2022
3.5 Bleeding Disorder Treatment Drug Key Players Head office and Area Served
3.6 Key Players Bleeding Disorder Treatment Drug Product Solution and Service
3.7 Date of Enter into Bleeding Disorder Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bleeding Disorder Treatment Drug Breakdown Data by Type
4.1 Global Bleeding Disorder Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Bleeding Disorder Treatment Drug Forecasted Market Size by Type (2024-2029)
5 Bleeding Disorder Treatment Drug Breakdown Data by Application
5.1 Global Bleeding Disorder Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Bleeding Disorder Treatment Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Bleeding Disorder Treatment Drug Market Size (2018-2029)
6.2 North America Bleeding Disorder Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Bleeding Disorder Treatment Drug Market Size by Country (2018-2023)
6.4 North America Bleeding Disorder Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bleeding Disorder Treatment Drug Market Size (2018-2029)
7.2 Europe Bleeding Disorder Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Bleeding Disorder Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Bleeding Disorder Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bleeding Disorder Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Bleeding Disorder Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Bleeding Disorder Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Bleeding Disorder Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bleeding Disorder Treatment Drug Market Size (2018-2029)
9.2 Latin America Bleeding Disorder Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Bleeding Disorder Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Bleeding Disorder Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bleeding Disorder Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Bleeding Disorder Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Bleeding Disorder Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Bleeding Disorder Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Detail
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Bleeding Disorder Treatment Drug Introduction
11.1.4 AbbVie Inc Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.1.5 AbbVie Inc Recent Development
11.2 Alnylam Pharmaceuticals Inc.
11.2.1 Alnylam Pharmaceuticals Inc. Company Detail
11.2.2 Alnylam Pharmaceuticals Inc. Business Overview
11.2.3 Alnylam Pharmaceuticals Inc. Bleeding Disorder Treatment Drug Introduction
11.2.4 Alnylam Pharmaceuticals Inc. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.2.5 Alnylam Pharmaceuticals Inc. Recent Development
11.3 Bayer AG
11.3.1 Bayer AG Company Detail
11.3.2 Bayer AG Business Overview
11.3.3 Bayer AG Bleeding Disorder Treatment Drug Introduction
11.3.4 Bayer AG Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.3.5 Bayer AG Recent Development
11.4 CSL Behring（CSL Limited）
11.4.1 CSL Behring（CSL Limited） Company Detail
11.4.2 CSL Behring（CSL Limited） Business Overview
11.4.3 CSL Behring（CSL Limited） Bleeding Disorder Treatment Drug Introduction
11.4.4 CSL Behring（CSL Limited） Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.4.5 CSL Behring（CSL Limited） Recent Development
11.5 Grifols S.A.
11.5.1 Grifols S.A. Company Detail
11.5.2 Grifols S.A. Business Overview
11.5.3 Grifols S.A. Bleeding Disorder Treatment Drug Introduction
11.5.4 Grifols S.A. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.5.5 Grifols S.A. Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Bleeding Disorder Treatment Drug Introduction
11.6.4 Johnson & Johnson Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Detail
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Bleeding Disorder Treatment Drug Introduction
11.7.4 Novo Nordisk A/S Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Detail
11.8.2 Octapharma AG Business Overview
11.8.3 Octapharma AG Bleeding Disorder Treatment Drug Introduction
11.8.4 Octapharma AG Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.8.5 Octapharma AG Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Bleeding Disorder Treatment Drug Introduction
11.9.4 Pfizer Inc. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.9.5 Pfizer Inc. Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Detail
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Bleeding Disorder Treatment Drug Introduction
11.10.4 Sanofi S.A. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.10.5 Sanofi S.A. Recent Development
11.11 Takeda Pharmaceutical Company Limited
11.11.1 Takeda Pharmaceutical Company Limited Company Detail
11.11.2 Takeda Pharmaceutical Company Limited Business Overview
11.11.3 Takeda Pharmaceutical Company Limited Bleeding Disorder Treatment Drug Introduction
11.11.4 Takeda Pharmaceutical Company Limited Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.11.5 Takeda Pharmaceutical Company Limited Recent Development
11.12 Wellona Pharma
11.12.1 Wellona Pharma Company Detail
11.12.2 Wellona Pharma Business Overview
11.12.3 Wellona Pharma Bleeding Disorder Treatment Drug Introduction
11.12.4 Wellona Pharma Revenue in Bleeding Disorder Treatment Drug Business (2018-2023)
11.12.5 Wellona Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bleeding Disorder Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Intravenous Injection
Table 4. Key Players of Others
Table 5. Global Bleeding Disorder Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Bleeding Disorder Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Bleeding Disorder Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Bleeding Disorder Treatment Drug Market Share by Region (2018-2023)
Table 9. Global Bleeding Disorder Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Bleeding Disorder Treatment Drug Market Share by Region (2024-2029)
Table 11. Bleeding Disorder Treatment Drug Market Trends
Table 12. Bleeding Disorder Treatment Drug Market Drivers
Table 13. Bleeding Disorder Treatment Drug Market Challenges
Table 14. Bleeding Disorder Treatment Drug Market Restraints
Table 15. Global Bleeding Disorder Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Bleeding Disorder Treatment Drug Market Share by Players (2018-2023)
Table 17. Global Top Bleeding Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bleeding Disorder Treatment Drug as of 2022)
Table 18. Ranking of Global Top Bleeding Disorder Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Bleeding Disorder Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bleeding Disorder Treatment Drug Product Solution and Service
Table 22. Date of Enter into Bleeding Disorder Treatment Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bleeding Disorder Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Bleeding Disorder Treatment Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Bleeding Disorder Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Bleeding Disorder Treatment Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Bleeding Disorder Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Bleeding Disorder Treatment Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Bleeding Disorder Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Bleeding Disorder Treatment Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Bleeding Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Bleeding Disorder Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Bleeding Disorder Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Bleeding Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Bleeding Disorder Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Bleeding Disorder Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Bleeding Disorder Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Bleeding Disorder Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Bleeding Disorder Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Bleeding Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Bleeding Disorder Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Bleeding Disorder Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Bleeding Disorder Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Bleeding Disorder Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Bleeding Disorder Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. AbbVie Inc Company Detail
Table 48. AbbVie Inc Business Overview
Table 49. AbbVie Inc Bleeding Disorder Treatment Drug Product
Table 50. AbbVie Inc Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 51. AbbVie Inc Recent Development
Table 52. Alnylam Pharmaceuticals Inc. Company Detail
Table 53. Alnylam Pharmaceuticals Inc. Business Overview
Table 54. Alnylam Pharmaceuticals Inc. Bleeding Disorder Treatment Drug Product
Table 55. Alnylam Pharmaceuticals Inc. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 56. Alnylam Pharmaceuticals Inc. Recent Development
Table 57. Bayer AG Company Detail
Table 58. Bayer AG Business Overview
Table 59. Bayer AG Bleeding Disorder Treatment Drug Product
Table 60. Bayer AG Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 61. Bayer AG Recent Development
Table 62. CSL Behring（CSL Limited） Company Detail
Table 63. CSL Behring（CSL Limited） Business Overview
Table 64. CSL Behring（CSL Limited） Bleeding Disorder Treatment Drug Product
Table 65. CSL Behring（CSL Limited） Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 66. CSL Behring（CSL Limited） Recent Development
Table 67. Grifols S.A. Company Detail
Table 68. Grifols S.A. Business Overview
Table 69. Grifols S.A. Bleeding Disorder Treatment Drug Product
Table 70. Grifols S.A. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 71. Grifols S.A. Recent Development
Table 72. Johnson & Johnson Company Detail
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Bleeding Disorder Treatment Drug Product
Table 75. Johnson & Johnson Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novo Nordisk A/S Company Detail
Table 78. Novo Nordisk A/S Business Overview
Table 79. Novo Nordisk A/S Bleeding Disorder Treatment Drug Product
Table 80. Novo Nordisk A/S Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 81. Novo Nordisk A/S Recent Development
Table 82. Octapharma AG Company Detail
Table 83. Octapharma AG Business Overview
Table 84. Octapharma AG Bleeding Disorder Treatment Drug Product
Table 85. Octapharma AG Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 86. Octapharma AG Recent Development
Table 87. Pfizer Inc. Company Detail
Table 88. Pfizer Inc. Business Overview
Table 89. Pfizer Inc. Bleeding Disorder Treatment Drug Product
Table 90. Pfizer Inc. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 91. Pfizer Inc. Recent Development
Table 92. Sanofi S.A. Company Detail
Table 93. Sanofi S.A. Business Overview
Table 94. Sanofi S.A. Bleeding Disorder Treatment Drug Product
Table 95. Sanofi S.A. Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 96. Sanofi S.A. Recent Development
Table 97. Takeda Pharmaceutical Company Limited Company Detail
Table 98. Takeda Pharmaceutical Company Limited Business Overview
Table 99. Takeda Pharmaceutical Company Limited Bleeding Disorder Treatment Drug Product
Table 100. Takeda Pharmaceutical Company Limited Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 101. Takeda Pharmaceutical Company Limited Recent Development
Table 102. Wellona Pharma Company Detail
Table 103. Wellona Pharma Business Overview
Table 104. Wellona Pharma Bleeding Disorder Treatment Drug Product
Table 105. Wellona Pharma Revenue in Bleeding Disorder Treatment Drug Business (2018-2023) & (US$ Million)
Table 106. Wellona Pharma Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bleeding Disorder Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Bleeding Disorder Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Intravenous Injection Features
Figure 5. Others Features
Figure 6. Global Bleeding Disorder Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Bleeding Disorder Treatment Drug Market Share by Application: 2022 VS 2029
Figure 8. Hemophilia A Case Studies
Figure 9. Hemophilia B Case Studies
Figure 10. Von Willebrand Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Bleeding Disorder Treatment Drug Report Years Considered
Figure 13. Global Bleeding Disorder Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Bleeding Disorder Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Bleeding Disorder Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Bleeding Disorder Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Bleeding Disorder Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bleeding Disorder Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Bleeding Disorder Treatment Drug Revenue in 2022
Figure 19. North America Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Bleeding Disorder Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Bleeding Disorder Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Bleeding Disorder Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Bleeding Disorder Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Bleeding Disorder Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Bleeding Disorder Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. AbbVie Inc Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 48. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 49. Bayer AG Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 50. CSL Behring（CSL Limited） Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 51. Grifols S.A. Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 53. Novo Nordisk A/S Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 54. Octapharma AG Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 55. Pfizer Inc. Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 56. Sanofi S.A. Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 57. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 58. Wellona Pharma Revenue Growth Rate in Bleeding Disorder Treatment Drug Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 腫瘍溶解性ウイルス薬物治療の世界市場2023年：フェーズ1、フェーズ2、その他
  • 薬剤耐性結核治療薬の世界市場2023年：第一類抗結核薬、第二類抗結核薬、その他
  • 出血性疾患治療の世界市場 2022年-2026年
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
  • 抗生物質の世界市場2023年：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7429 )"出血性疾患治療薬の世界市場2023年：経口式、静脈注射式、その他" (英文：Global Bleeding Disorder Treatment Drug Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。